1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

New Disease Registries Support Comparative Effectiveness Research Priorities

RemedyMD’s solutions address Institute of Medicine’s top 100 priorities and shift focus toward use of more comprehensive scientific evidence

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Oct 26, 2009 -
SALT LAKE CITY, Utah

RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease, and clinical registries in the next 90 days.

Details about the registry: http://www.remedymd.com/cer100/

Developed to support the Institute of Medicine’s 100 top priorities for comparative effectiveness research (CER), these registries allow users to:
•   Access existing data stores
•   Easily collect new data elements
•   Report across all phenotypic and genotypic data simultaneously

As a result, clinicians and researchers will be able to dramatically improve their effectiveness as they search for which interventions are most appropriate for specific patient populations.

“Our experience has shown that when you view and report across all data types at the same time, you discover patterns and associations that were previously indistinguishable using traditional methodologies”, said Gary Kennedy, Founder and CEO of RemedyMD.

RemedyMD’s disease registry software effectively utilizes a combination of applications, tools and data infrastructure enabling clinicians and researchers to electronically collect and validate data, access and leverage other non-centralized data stores, while reporting and visualizing trends across all data types simultaneously.  

“We’ve invested heavily over the past several years developing a platform that allows us to quickly create and personalize specialty-specific registries that address the requirement of AHRQ grants for CER”, said Adam Slovik, President and COO of RemedyMD. “Our Mosaic platform allows researchers to leverage disparate data sources, collaborate with colleagues and personalize research initiatives all without the help of IT.”

For more information about comparative effectiveness research and clinical registries visit: http://www.remedymd.com/cer100/.

RemedyMD Registry Resources:
Ways to Leverage New Registries: http://www.remedymd.com/cer100/

Comparative Effectiveness Research:  http://www.remedymd.com/cer_home.html

Clinical Registries: www.remedymd.com/registries_home.html

Disease Registry Software: http://www.remedymd.com/registries_home.html

Institute of Medicine’s Top 100 Priorities for CER: www.remedymd.com/cer_kit

About RemedyMD
RemedyMD® is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, disease, and patient registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider’s preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes. For more information, visit http://www.RemedyMD.com.

Press Contact
Lane Peterson
801.733.3383
lpeterson@remedymd.com

--- end ---

Click to Share

Contact Email:
***@remedymd.com Email Verified
Issued By:RemedyMD
Phone:(801) 733-3300
Fax:(801) 733-3301
Address:9350 South 150 East
:Suite 850
Zip:84070
City/Town:Salt Lake City
State/Province:Utah
Country:United States
Industry:Health, Software, Medical
Tags:, , , ,
Last Updated:Oct 23, 2009
Shortcut:http://prlog.org/10386807
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share